Angiogenesis, Inflammation & Therapeutics | Online ISSN  2207-872X
RESEARCH ARTICLE   (Open Access)

Immunoglobulin G Seroprevalence of Lassa Fever Virus Among Individuals Residing Along the Banks of River Niger in Anambra State, Nigeria.

Umezurike Kingsley Chimuanya1, Chukwuma Oluchukwu Mariagoretti1,2, Ochiabuto Mary Barbara1, Manafa Patrick Onochie1, Ntum Ifeanyichukwu Michael1, Chukwuma George Okechukwu1,2

+ Author Affiliations

Journal of Angiotherapy 6(2) 696-702 https://doi.org/10.25163/angiotherapy.626323

Submitted: 09 October 2022  Revised: 22 November 2022  Published: 22 November 2022 

Abstract

Background – Lassa fever (LF) is an acute viral haemorrhagic fever caused by the Lassa virus belonging to the Arenaviridae family. It is a zoonotic infection that is widespread in West Africa. Transmission occurs through exposure to rodent excreta and secretions and via the bodily fluids of an infected person. This study aimed to determine the Lassa fever-specific IgG seroprevalence among individuals who reside along the banks of River Niger in Anambra state, Nigeria.  Materials and methods – Ethical approval was obtained from the ethics committee of the College of Health Sciences, Nnamdi Azikiwe University Awka. Informed consent was sought and a questionnaire was administered. For this study, 90 subjects were recruited from the Okpoko community of Ogbaru LGA of Anambra state, Nigeria. Blood samples were collected and analysed at the Molecular Research laboratory using the Enzyme-linked Immunosorbent Assay (ELISA) technique to screen for LF-specific IgG. Results – LF-specific IgG was detected in 14 out of 90 Subjects, giving a prevalence rate of 15.6%. In addition, some risk factors were ascertained, and the relationship between LF IgG seroprevalence and age, gender, and Body Mass Index (BMI) were assessed though there were no significant relationships. Conclusion – A significant LF seroprevalence was revealed among the sampled population, which could pose a serious public health threat. Intervention strategies should be implemented to check possible LF outbreaks in the sampled area, and further epidemiologic studies should be done to determine the means of spread and risk factors of Lassa fever.

Keywords: Lassa fever, Seroprevalence, River Banks, Immunoglobulin G, Mastomys natalensis

References

Ajaero CK and Mozie AT. (2014). Socio-demographic differentials in vulnerability to flood disasters in rural Southeastern Nigeria. International Seminar on Demographic Differential Vulnerability to Natural Disasters in the Context of Climate Change Adaptation, organised by IUSSP in collaboration with Chulalongkorn University Bangkok and the Wittgenstein Centre for Demography and Global Human Capital (IIASA, VID/OAW, WU) held in Kao Lak, Thailand.

Bonner PC, Schmidt WP, Belmain SR, Oshin B, Baglole D, Borchert M. (2007). Poor housing quality increases risk of rodent infestation and Lassa fever in refugee camps of Sierra Leone. American Journal  of Tropical Medicine and Hygiene, 77: 169–75.

Centre for Disease Control and Prevention (CDC) (2014). Lassa fever fact sheet. Available: http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/factsheets/lassa_fever_factsheet.pdf. Accessed September, 2019.

Clegg J C (2009). Influence of Climate Change on the Incidence and Impact of Arena virus disease: a speculative assessment. Clinical Microbiology and Infections, 15: 504–9.

Connolly MA, Gayer M, Ryan MJ, Salama P, Spiegel P, Heymann DL. (2004). Communicable diseases in complex emergencies: Impact and challenges. Lancet, 364:1974-83.

Fichet-Calvet E, Becker-Ziaja B, Koivogui L, Gu¨nther S. (2014). Lassa serology in natural populations of rodents and horizontal transmission. Vector-Borne Zoonotic Diseases, 14:665-74.

Fitchet-Calvet E, LeCompte E, Koivogui L. (2008). Reproductive characteristics of Mastomys natalensis and Lassa virus prevalence of in Guinea, West Africa. Vector-Borne Zoonotic Diseases, 8(1): 41-8.

Fraser DW, Campbell CC, Monath TP, Goff PA, Gregg MB. (1974). Lassa fever in the eastern province of Sierra Leone, 1970–1972. American Journal of Tropical Medicine and Hygiene 23:1131–9.

Ilori EA, Furuse Y, Ipadeola OB, Dan-Nwafor CC, Abubakar A, Womi-Eteng OE et al. (2019). Epidemiologic and clinical features of Lassa fever outbreak in Nigeria, January 1 – May 6, 2018. Emerging Infectious Diseases, 25(6): 1066-74.

Kerneis S, Koivogui L, Magassouba N, Koulemou K, Lewis R et al. (2009). Prevalence and risk factors of Lassa seropositivity in Inhabitants of the forest region of Guinea: A cross-sectional study. PLoS Neglected Tropical Disease, 3(11): e548.

Monath TP. (1975). Lassa fever: review of epidemiology and epizootiology. Bulletin of the World Health Organization, 52(4–6): 577–92. PMID: 782738

Ogbu O, Ajuluchukwu E and Uneke CJ. (2007). Lassa fever in West Africa sub-region: an overview. Journal of Vector Borne Disease, 44(1):1-11.

Okoye PU, Ezeokoli FO, Ezeokonkwo JU. (2015). Building development practice in flood prone area: case of Ogbaru Council Area of Anambra State Nigeria. International Journal of Engineering Research and Applications, 5(8): 30-40.

Okoye PU, Ezeokonkwo JU, Mbakwe CC. (2017). Survey of housing conditions and improvement strategies in Okpoko peri-urban settlement of Anambra state, Nigeria. Architecture Research, 7(4):168-83.

Tambo E, Adetunde OT, Olalubi OA. (2018). Re-emerging Lassa fever outbreaks in Nigeria: Re-enforcing “One Health” community surveillance and emergence response practice. Infectious Diseases and Poverty, 7:37.

Tobin E, Asogun D, Isah E, Ugege O, Ebhodaghe P. (2013). Assessment of knowledge and attitude towards Lassa fever among Primary care providers in an endemic suburban community of Edo state: implications for control. Journal of Medical Science., 4(8):311–8.

Tobin EA, Asogun D, Akpede N, Adomeh D, Odia I, Gunther S. (2015). Lassa fever in Nigeria: Insights into seroprevalence and risk factors in rural Edo state. A pilot study. Journal of Medicine in the Tropics, 17:51-5.

World Health Organization (WHO) (2012). Lassa fever in Nigeria: Global alert and response. Available at http://www.who.int/csr/don/2012_04_04/en/. Accessed October, 2019.

PDF
Full Text
Export Citation

View Dimensions


View Plumx



View Altmetric



9
Save
0
Citation
669
View
1
Share